Literature DB >> 16877039

Acute heart failure associated with high admission blood pressure--a distinct vascular disorder?

Olga Milo-Cotter1, Kirkwood F Adams, Christopher M O'Connor, Nir Uriel, Edo Kaluski, G Michael Felker, Beth Weatherley, Zvi Vered, Gad Cotter.   

Abstract

BACKGROUND: Although blood pressure (BP) is elevated in patients with acute heart failure (AHF), first admission BP has not been meticulously recorded before treatment in previous studies.
METHODS: During three consecutive months, all AHF admissions (335 patients) to a city hospital which provides the sole inpatient medical service for approximately 500,000 people were registered. First BP was recorded before treatment at the first patient encounter in the ambulance or the emergency room.
RESULTS: Mean BP at admission was 164+/-38/88+/-22 mm Hg. Mean BP in the highest quartile was 212+/-22/115+/-13 mm Hg. Patients with higher baseline BP had higher ejection fraction (highest versus lowest quartile 48+/-13% vs. 33+/-14%, p<0.001), less atrial fibrillation (18% vs. 42%, p=0.001) as well as lower mean urea and higher mean haemoglobin. The apparently more favourable baseline characteristics in patients with higher admission BP did not translate into lower morbidity - the rate of worsening heart failure - was not related to admission BP. However, 6 month mortality was lower in patients with higher admission BP (4% vs. 19.3%, p=0.002).
CONCLUSIONS: Blood pressure is elevated substantially at the onset of AHF. The different characteristics and outcome of patients admitted with high-BP associated AHF suggest that this presentation may be a specific disorder related to a distinct yet unknown pathophysiological mechanism.

Entities:  

Mesh:

Year:  2006        PMID: 16877039     DOI: 10.1016/j.ejheart.2006.06.004

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  10 in total

Review 1.  Decongestion in acute heart failure.

Authors:  Robert J Mentz; Keld Kjeldsen; Gian Paolo Rossi; Adriaan A Voors; John G F Cleland; Stefan D Anker; Mihai Gheorghiade; Mona Fiuzat; Patrick Rossignol; Faiez Zannad; Bertram Pitt; Christopher O'Connor; G Michael Felker
Journal:  Eur J Heart Fail       Date:  2014-03-05       Impact factor: 15.534

2.  Hospital admissions of hypertension, angina, myocardial infarction and ischemic heart disease peaked at physiologically equivalent temperature 0°C in Germany in 2009-2011.

Authors:  Ivy Shiue; David R Perkins; Nick Bearman
Journal:  Environ Sci Pollut Res Int       Date:  2015-08-20       Impact factor: 4.223

3.  Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study.

Authors:  Marco Metra; John R Teerlink; G Michael Felker; Barry H Greenberg; Gerasimos Filippatos; Piotr Ponikowski; Sam L Teichman; Elaine Unemori; Adriaan A Voors; Beth Davison Weatherley; Gad Cotter
Journal:  Eur J Heart Fail       Date:  2010-08-22       Impact factor: 15.534

4.  M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.

Authors:  Paul M McKie; Alessandro Cataliotti; Tomoko Ichiki; S Jeson Sangaralingham; Horng H Chen; John C Burnett
Journal:  J Am Heart Assoc       Date:  2014-01-02       Impact factor: 5.501

5.  Hemodynamic effects of inotropic drugs in heart failure: A network meta-analysis of clinical trials.

Authors:  Ling Long; Hao-Tian Zhao; Li-Min Shen; Cong He; Shan Ren; He-Ling Zhao
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

6.  Arterial stiffening is a crucial factor for left ventricular diastolic dysfunction in a community-based normotensive population.

Authors:  Maeda Mika; Hideaki Kanzaki; Takuya Hasegawa; Hiroki Fukuda; Makoto Amaki; Jiyoong Kim; Masanori Asakura; Hiroshi Asanuma; Motonobu Nishimura; Masafumi Kitakaze
Journal:  Int J Cardiol Hypertens       Date:  2020-06-20

Review 7.  Relaxin, a pleiotropic vasodilator for the treatment of heart failure.

Authors:  Sam L Teichman; Elaine Unemori; Thomas Dschietzig; Kirk Conrad; Adriaan A Voors; John R Teerlink; G Michael Felker; Marco Metra; Gad Cotter
Journal:  Heart Fail Rev       Date:  2008-12-20       Impact factor: 4.214

Review 8.  Vasodilators in the treatment of acute heart failure: what we know, what we don't.

Authors:  Marco Metra; John R Teerlink; Adriaan A Voors; G Michael Felker; Olga Milo-Cotter; Beth Weatherley; Howard Dittrich; Gad Cotter
Journal:  Heart Fail Rev       Date:  2008-12-19       Impact factor: 4.214

Review 9.  Classical inotropes and new cardiac enhancers.

Authors:  John T Parissis; Dimitrios Farmakis; Markku Nieminen
Journal:  Heart Fail Rev       Date:  2007-06       Impact factor: 4.654

10.  Perturbations of pulsatile hemodynamics and clinical outcomes in patients with acute heart failure and reduced, mid-range or preserved ejection fraction.

Authors:  Wei-Ming Huang; Shih-Hsien Sung; Wen-Chung Yu; Hao-Min Cheng; Chi-Jung Huang; Chao-Yu Guo; Dai-Yin Lu; Ching-Wei Lee; Chen-Huan Chen
Journal:  PLoS One       Date:  2019-08-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.